Quadrant Capital Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,712
| Closed | -$15.7K | – | 1959 |
|
|
2025
Q1 | $15.7K | Sell |
4,712
-347
| -7% | -$1.16K | ﹤0.01% | 2101 |
|
|
2024
Q4 | $37.4K | Hold |
5,059
| – | – | ﹤0.01% | 1577 |
|
|
2024
Q3 | $47.5K | Hold |
5,059
| – | – | ﹤0.01% | 1480 |
|
|
2024
Q2 | $40.6K | Hold |
5,059
| – | – | ﹤0.01% | 1511 |
|
|
2024
Q1 | $75K | Hold |
5,059
| – | – | 0.01% | 1153 |
|
|
2023
Q4 | $41.1K | Buy |
5,059
+4,678
| +1,228% | +$38K | ﹤0.01% | 1495 |
|
|
2023
Q3 | $1.73K | Sell |
381
-1,433
| -79% | -$6.52K | ﹤0.01% | 2423 |
|
|
2023
Q2 | $12.8K | Buy |
1,814
+130
| +8% | +$915 | ﹤0.01% | 1911 |
|
|
2023
Q1 | $10.3K | Hold |
1,684
| – | – | ﹤0.01% | 2014 |
|
|
2022
Q4 | $10.8K | Buy |
1,684
+1,552
| +1,176% | +$9.92K | ﹤0.01% | 1910 |
|
|
2022
Q3 | $1K | Sell |
132
-127
| -49% | -$962 | ﹤0.01% | 2522 |
|
|
2022
Q2 | $3K | Sell |
259
-22
| -8% | -$255 | ﹤0.01% | 2113 |
|
|
2022
Q1 | $4K | Sell |
281
-736
| -72% | -$10.5K | ﹤0.01% | 1975 |
|
|
2021
Q4 | $19K | Buy |
1,017
+244
| +32% | +$4.56K | ﹤0.01% | 1334 |
|
|
2021
Q3 | $19K | Buy |
773
+545
| +239% | +$13.4K | ﹤0.01% | 1261 |
|
|
2021
Q2 | $6K | Buy |
228
+161
| +240% | +$4.24K | ﹤0.01% | 1777 |
|
|
2021
Q1 | $2K | Buy |
67
+2
| +3% | +$60 | ﹤0.01% | 2074 |
|
|
2020
Q4 | $3K | Buy |
65
+31
| +91% | +$1.43K | ﹤0.01% | 1838 |
|
|
2020
Q3 | $1K | Buy |
+34
| New | +$1K | ﹤0.01% | 1996 |
|
|
2020
Q2 | – | Sell |
-150
| Closed | -$4K | – | 2305 |
|
|
2020
Q1 | $4K | Buy |
+150
| New | +$4K | ﹤0.01% | 1702 |
|